Sudden Cardiac Death Among Adolescents in the United Kingdom.


Journal

Journal of the American College of Cardiology
ISSN: 1558-3597
Titre abrégé: J Am Coll Cardiol
Pays: United States
ID NLM: 8301365

Informations de publication

Date de publication:
21 03 2023
Historique:
received: 13 12 2022
revised: 12 01 2023
accepted: 17 01 2023
entrez: 15 3 2023
pubmed: 16 3 2023
medline: 21 3 2023
Statut: ppublish

Résumé

Causes and precipitating factors of sudden cardiac death (SCD) in adolescents are poorly understood. The authors sought to investigate the etiologies of SCD and their association with physical activity in a large cohort of adolescents. Between 1994 and June 2022, 7,675 cases of SCD were consecutively referred to our national cardiac pathology center; 756 (10%) were adolescents. All cases underwent detailed autopsy evaluation by expert cardiac pathologists. Clinical information was obtained from referring coroners. A structurally normal heart, indicative of sudden arrhythmic death syndrome was the most common autopsy finding (n = 474; 63%). Myocardial diseases were detected in 163 cases (22%), including arrhythmogenic cardiomyopathy (n = 36; 5%), hypertrophic cardiomyopathy (n = 31; 4%), idiopathic left ventricular hypertrophy (n = 31; 4%), and myocarditis (n = 30; 4%). Coronary artery anomalies were identified in 17 cases (2%). Decedents were competitive athletes in 128 cases (17%), and 159 decedents (21%) died during exercise. Arrhythmogenic cardiomyopathy was diagnosed in 8% of athletes compared with 4% of nonathletes (P = 0.05); coronary artery anomalies were significantly more common in athletes (9% vs 1%; P < 0.001), as well as commotio cordis (5% compared with 1% in nonathletes; P = 0.001). The 3 main comorbidities were asthma (n = 58; 8%), epilepsy (n = 44; 6%), and obesity (n = 40; 5%). Sudden arrhythmic death syndrome and myocardial diseases are the most common conditions diagnosed at autopsy in adolescent victims of SCD. Among causes of SCD, arrhythmogenic cardiomyopathy, coronary artery anomalies, and commotio cordis are more common in young athletes than in similar age sedentary individuals.

Sections du résumé

BACKGROUND
Causes and precipitating factors of sudden cardiac death (SCD) in adolescents are poorly understood.
OBJECTIVES
The authors sought to investigate the etiologies of SCD and their association with physical activity in a large cohort of adolescents.
METHODS
Between 1994 and June 2022, 7,675 cases of SCD were consecutively referred to our national cardiac pathology center; 756 (10%) were adolescents. All cases underwent detailed autopsy evaluation by expert cardiac pathologists. Clinical information was obtained from referring coroners.
RESULTS
A structurally normal heart, indicative of sudden arrhythmic death syndrome was the most common autopsy finding (n = 474; 63%). Myocardial diseases were detected in 163 cases (22%), including arrhythmogenic cardiomyopathy (n = 36; 5%), hypertrophic cardiomyopathy (n = 31; 4%), idiopathic left ventricular hypertrophy (n = 31; 4%), and myocarditis (n = 30; 4%). Coronary artery anomalies were identified in 17 cases (2%). Decedents were competitive athletes in 128 cases (17%), and 159 decedents (21%) died during exercise. Arrhythmogenic cardiomyopathy was diagnosed in 8% of athletes compared with 4% of nonathletes (P = 0.05); coronary artery anomalies were significantly more common in athletes (9% vs 1%; P < 0.001), as well as commotio cordis (5% compared with 1% in nonathletes; P = 0.001). The 3 main comorbidities were asthma (n = 58; 8%), epilepsy (n = 44; 6%), and obesity (n = 40; 5%).
CONCLUSIONS
Sudden arrhythmic death syndrome and myocardial diseases are the most common conditions diagnosed at autopsy in adolescent victims of SCD. Among causes of SCD, arrhythmogenic cardiomyopathy, coronary artery anomalies, and commotio cordis are more common in young athletes than in similar age sedentary individuals.

Identifiants

pubmed: 36922085
pii: S0735-1097(23)00331-5
doi: 10.1016/j.jacc.2023.01.041
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1007-1017

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2023 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Funding Support and Author Disclosures The charity Cardiac Risk in the Young fund the Cardiac Risk in the Young Cardiovascular Pathology Laboratories. Dr Finocchiaro is partly funded by the charity Cardiac Risk in the Young. Dr Westaby is funded by the National Institute for Health and Care Research. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.

Auteurs

Gherardo Finocchiaro (G)

Cardiovascular Sciences Research Centre, St George's, University of London, London, United Kingdom; Cardiothoracic Centre, Guy's and St Thomas' Hospital, London, United Kingdom; King's College London, London, United Kingdom; Cardiovascular Research Centre, Royal Brompton and Harefield NHS Foundation Trust, London, United Kingdom.

Davide Radaelli (D)

Cardiovascular Sciences Research Centre, St George's, University of London, London, United Kingdom; Department of Medicine, Surgery and Health, University of Trieste, Trieste, Italy.

Stefano D'Errico (S)

Department of Medicine, Surgery and Health, University of Trieste, Trieste, Italy.

Michael Papadakis (M)

Cardiovascular Sciences Research Centre, St George's, University of London, London, United Kingdom.

Elijah R Behr (ER)

Cardiovascular Sciences Research Centre, St George's, University of London, London, United Kingdom.

Sanjay Sharma (S)

Cardiovascular Sciences Research Centre, St George's, University of London, London, United Kingdom.

Joseph Westaby (J)

Cardiovascular Sciences Research Centre, St George's, University of London, London, United Kingdom.

Mary N Sheppard (MN)

Cardiovascular Sciences Research Centre, St George's, University of London, London, United Kingdom. Electronic address: msheppar@sgul.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH